Implementation of Teledermoscopy and Artificial Intelligence
Recruiting · NCT05033678 · Observational (researchers observe without assigning treatment) · Lead sponsor: Region Skane
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The study has 2 parts. Part 1 will investigate the effects of introducing teledermoscopy in clinical practice, more specifically the change in referral patterns, the risk of undetected skin cancers and the effect on diagnostic accuracy in general practitioners. Part 2 will investigate how to introduce artificial intelligence (AI) within teledermocsopy. In this study the investigators will measure the diagnostic accuracy of teledermoscopic assessors that had access to the results of artificial intelligence algorithm compared to those who did not. Data will be collected through teledermoscopic referrals, patient records, national registries and questionnairs.
Who can take part
Inclusion criteria
- Has a skin lesion assessed by a physician during a visit
- The physician decides to create a teledermoscopy referral
Exclusion criteria
- inability or unwillingness to participate in the study
- the patient is younger than 15 years old
- Images of such bad quality they cannot be assessed
Where it is running
1 location listed.
- Department of dermatology, Skane University Hospital - Lund, Sweden